Kumar, A.H. and George, M. 2021. Evaluating the Chrono-pharmacology of Icosapent Ethyl to Assess its Therapeutic Efficacy in Reducing Hypertriglyceridemia Associated Cardiovascular Events. Biology, Engineering, Medicine and Science Reports. 5, 2 (Feb. 2021), 26–28. DOI:https://doi.org/10.5530/bems.5.2.9.